MusclePharm Named Official Supplement Provider of New Pro Golf Tour, the Xempt Players Series
February 28 2011 - 8:30AM
MusclePharm Corporation, a Nevada corporation ("MusclePharm" or the
"Company") (OTCBB:MSLP), an expanding U.S. nutritional supplement
company, is pleased to announce that it will be the official
supplement provider of the Xempt Player Series (XPS), a new
professional golf tour that will debut in April 2011.
The Xempt Player Series is open to men, women and seniors who
have aspirations of playing professional golf. The debuting series
will feature participants competing from all over the United
States, with each participant vying for part of the $200,000 total
purse that is up for grabs at the XPS Championship in August.
MusclePharm's sponsorship of the XPS also signals the
introduction of its innovative MuscleGel product into the golf
market. Each professional golfer at all 31 nationwide XPA
tournaments will receive MuscleGel during tournament play. The
convenient gel-based formula, which has drawn favorable reviews
since its introduction, offers high-quality protein that can be
consumed on the go without liquids or mixing.
"The XPS is a tour that is great for an aspiring golfer who is
trying to make it to the next level and I am very excited to have a
major brand like MusclePharm on board to support their dream of
playing professional golf," XPS CEO and Founder Gerry Hammond said.
"MuscleGel is one of the best products I have ever used and it will
be perfect in a golf-tour setting. These players need something
light that they can carry with them on the course, and MuscleGel is
an incredibly convenient and high-quality product."
The XPS' stroke play competition will start with as many as 120
golfers competing at each local XPS qualifying tournament across
the United States. Those who qualify will then take part in one of
five regional qualifier tournaments, with 24 players advancing from
each region to the year-end XPS championship. The XPS champion
will win more than $86,000 in prize money and benefits, making it
an ideal stage for MusclePharm to introduce Muscle Gel to the golf
marketplace.
"MusclePharm considers itself 'The Athlete's Company' and our
goal is to make an impact in every sport. We are excited to be
working with the XPS and we look forward to its launch in April,"
MusclePharm President Cory Gregory said. "This grassroots approach
will help get MuscleGel into golfer's hands and we are confident
they will like the product. It will be an easy and convenient way
for the golf community to get protein during their match play, as
well being a great recovery tool for these athletes after playing
as much as 36 holes over two days."
For more information on the XPS, visit
www.xemptplayerseries.com.
About MusclePharm Corporation
Headquartered in Denver, Colorado, MusclePharm is a healthy
life-style company that develops and manufactures a full line of
National Science Foundation approved nutritional supplements that
are 100% free of banned substances. Based on years of research,
MusclePharm products are created through an advanced six-stage
research protocol involving the expertise of top nutritional
scientists and field tested by more than one hundred elite
professional athletes from various professional sports leagues
including the National Football League, Mixed Martial Arts, and
Major League Baseball. The Company's products address all
categories of an active lifestyle, including muscle building,
weight loss, and maintaining general fitness through a daily
nutritional supplement regimen. MusclePharm is sold in over 120
countries and available in over 5,000 U.S. retail outlets,
including GNC and Vitamin Shoppe. MusclePharm products are also
sold in over 100 online stores, including bodybuilding.com,
Amazon.com and Vitacost.com. For more information, please visit
www.musclepharm.com.
Forward Looking Statements
The information contained herein includes forward-looking
statements. These statements relate to future events or to our
future financial performance, and involve known and unknown risks,
uncertainties and other factors that may cause our actual results,
levels of activity, performance, or achievements to be materially
different from any future results, levels of activity, performance
or achievements expressed or implied by these forward-looking
statements. You should not place undue reliance on forward-looking
statements since they involve known and unknown risks,
uncertainties and other factors which are, in some cases, beyond
our control and which could, and likely will, materially affect
actual results, levels of activity, performance or achievements.
Any forward-looking statement reflects our current views with
respect to future events and is subject to these and other risks,
uncertainties and assumptions relating to our operations, results
of operations, growth strategy and liquidity. We assume no
obligation to publicly update or revise these forward-looking
statements for any reason, or to update the reasons actual results
could differ materially from those anticipated in these
forward-looking statements, even if new information becomes
available in the future. The safe harbor for forward-looking
statements contained in the Securities Litigation Reform Act of
1995 protects companies from liability for their forward-looking
statements if they comply with the requirements of the Act.
CONTACT: Investor Contact:
Cory Gregory,
President
investors@musclepharm.com
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From May 2024 to Jun 2024
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From Jun 2023 to Jun 2024